Unknown PHASE3 INTERVENTIONAL 1-arm NCT00478790

Ologen(Oculusgen)-Glaucoma and Pterygium Historical Control Study in China Shanghai Sixth People's Hospital

Study of the Safety and Effectiveness of the Ologen(OculusGen) Collagen Matrix Implant as an Aid in Glaucoma and Pterygium Surgery

Sponsor: Pro Top & Mediking Company Limited

Conditions Glaucomas Pterygium

Interventions ologen™ Collagen matrix implantation in glaucoma filtering surgery

Updated 5 times since 2017 Last updated: Oct 6, 2011 Started: Feb 28, 2007 Primary completion: Oct 31, 2011 Completion: Oct 31, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00478790, this PHASE3 trial focuses on Glaucomas and Pterygium and remains ongoing. Sponsored by Pro Top & Mediking Company Limited, it has been updated 5 times since 2007, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE3
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE3

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE3
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE3
Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE3

First recorded

Feb 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Pro Top & Mediking Company Limited

Data source: Pro Top & Mediking Company Limited

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Shanghai, China